BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 12384559)

  • 1. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
    Scotton CJ; Wilson JL; Scott K; Stamp G; Wilbanks GD; Fricker S; Bridger G; Balkwill FR
    Cancer Res; 2002 Oct; 62(20):5930-8. PubMed ID: 12384559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt.
    Barbero S; Bonavia R; Bajetto A; Porcile C; Pirani P; Ravetti JL; Zona GL; Spaziante R; Florio T; Schettini G
    Cancer Res; 2003 Apr; 63(8):1969-74. PubMed ID: 12702590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CXCL12 in metastasis of human ovarian cancer.
    Jiang YP; Wu XH; Xing HY; DU XY
    Chin Med J (Engl); 2007 Jul; 120(14):1251-5. PubMed ID: 17697577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation.
    Porcile C; Bajetto A; Barbieri F; Barbero S; Bonavia R; Biglieri M; Pirani P; Florio T; Schettini G
    Exp Cell Res; 2005 Aug; 308(2):241-53. PubMed ID: 15921680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis.
    Fukuda S; Broxmeyer HE; Pelus LM
    Blood; 2005 Apr; 105(8):3117-26. PubMed ID: 15618475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].
    Jiang YP; Wu XH; Xing HY; DU XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):403-7. PubMed ID: 17697603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
    Kijima T; Maulik G; Ma PC; Tibaldi EV; Turner RE; Rollins B; Sattler M; Johnson BE; Salgia R
    Cancer Res; 2002 Nov; 62(21):6304-11. PubMed ID: 12414661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.
    Lee BC; Lee TH; Avraham S; Avraham HK
    Mol Cancer Res; 2004 Jun; 2(6):327-38. PubMed ID: 15235108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.
    Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L
    Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma.
    Uchida D; Begum NM; Almofti A; Nakashiro K; Kawamata H; Tateishi Y; Hamakawa H; Yoshida H; Sato M
    Exp Cell Res; 2003 Nov; 290(2):289-302. PubMed ID: 14567988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of stromal derived factor-1alpha (SDF-1alpha) to CXCR4 chemokine receptor in normal human megakaryoblasts but not in platelets induces phosphorylation of mitogen-activated protein kinase p42/44 (MAPK), ELK-1 transcription factor and serine/threonine kinase AKT.
    Majka M; Ratajczak J; Kowalska MA; Ratajczak MZ
    Eur J Haematol; 2000 Mar; 64(3):164-72. PubMed ID: 10997882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways.
    Vlahakis SR; Villasis-Keever A; Gomez T; Vanegas M; Vlahakis N; Paya CV
    J Immunol; 2002 Nov; 169(10):5546-54. PubMed ID: 12421931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation.
    Brand S; Dambacher J; Beigel F; Olszak T; Diebold J; Otte JM; Göke B; Eichhorst ST
    Exp Cell Res; 2005 Oct; 310(1):117-30. PubMed ID: 16125170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
    Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D
    Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells.
    Hwang JH; Hwang JH; Chung HK; Kim DW; Hwang ES; Suh JM; Kim H; You KH; Kwon OY; Ro HK; Jo DY; Shong M
    J Clin Endocrinol Metab; 2003 Jan; 88(1):408-16. PubMed ID: 12519884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
    Zheng N; Chen J; Li T; Liu W; Liu J; Chen H; Wang J; Jia L
    Mol Carcinog; 2017 Aug; 56(8):1896-1908. PubMed ID: 28277622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion.
    Leelawat K; Leelawat S; Narong S; Hongeng S
    World J Gastroenterol; 2007 Mar; 13(10):1561-8. PubMed ID: 17461449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro.
    Liu Y; Ren CC; Yang L; Xu YM; Chen YN
    J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial cancer cell migration: a role for chemokine receptors?
    Scotton CJ; Wilson JL; Milliken D; Stamp G; Balkwill FR
    Cancer Res; 2001 Jul; 61(13):4961-5. PubMed ID: 11431324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human melanoma metastases express functional CXCR4.
    Scala S; Giuliano P; Ascierto PA; Ieranò C; Franco R; Napolitano M; Ottaiano A; Lombardi ML; Luongo M; Simeone E; Castiglia D; Mauro F; De Michele I; Calemma R; Botti G; Caracò C; Nicoletti G; Satriano RA; Castello G
    Clin Cancer Res; 2006 Apr; 12(8):2427-33. PubMed ID: 16638848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.